Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

First author publication for final year medical student on Parkinson’s Disease review

Patrick Oliver, a final year medical student at Oxford, has worked with Oxford Parkinson’s Disease Centre to get a first author publication on a new review of the gut brain axis in Parkinson’s disease.

an image of a brain and intestine with arrows pointing between them © Shutterstock


Current treatments for Parkinson’s disease (PD) improve motor symptoms but do not offer a cure. Recently, studies have suggested the poor clinical efficacy of existing treatments might be because they ignore a key element in the development of the disease: the gut microbiome.

A recent review paper, authored by Oxford medical student Patrick Oliver, with Livia Civitelli and Michele Hu from the OPDC, referenced over 200 studies in the field to explore evidence for a gut-first model of PD.

The review outlines current mechanistic understanding and support for a gut-first model of PD and looks at strengths and limitations of gut-based interventions, including probiotics, antibiotics, and faecal microbiome transplants.  It also suggests future directions for studies in the gut microbiome, including using longitudinal prospective cohorts of individuals with REM sleep behaviour disorder (RBD) and prodromal PD to identify the early changes that drive Parkinson’s Disease.

Patrick Oliver, Oxford Medical Student

Patrick says: ‘The inspiration for writing the review came from a new research project that I am working on together with Michele Hu, Jethro Johnson at the Kennedy Institute, and other collaborators which received funding from the John Fell fund. We found that focusing on the gut microbiome could enable earlier identification and intervention for Parkinson’s disease.’

Michele Hu added ‘It has been a real pleasure to work with Patrick, a dedicated and talented final year medical student at Oxford. He led a successful John Fell funding application to test the fecal microbiome in our Discovery PD and RBD cohort, working with the team to facilitate sample collection to ensure success. Having now written up this excellent review article on the subject as a medical student, I am looking forward to supporting his future research outputs as a qualified doctor! Many congratulations Patrick!’

Read the full review  ‘Exploring the role of the gut microbiome in early Parkinson’s disease and whether this offers novel avenues for new therapeutic interventions.’



Similar stories

Oxford researchers uncover how Parkinson's disease protein damages brain cells

A new study reveals a key mechanism by which the protein alpha-synuclein, the hallmark of Parkinson's disease, damages neurons (brain cells) by blocking a vital cellular gateway. The results of the study, published in Nature Communications, help to explain how the disease begins and highlights a potential new target for treatment.

New Lancet review calls for urgent action to tackle the growing global threat of encephalitis

The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.

Dr Ruxandra Dafinca awarded an Alzheimer’s Society Dementia Research Leader Fellowship

Ruxandra Dafinca is one of 17 early career researchers awarded a fellowship in the 2025/2026 call for her project focused on frontotemporal dementia.

New study shows the brain uses brief, slow rhythms to organise how memories are formed, stored, and later recalled

A new study from the University of Oxford and CNRS has shown that the brain uses rhythms for brain cell impulses to coordinate activity across memory-related regions in the brain during learning and help reactivate those experiences afterwards, strengthening what we remember.

Two researchers from NDCN join global network to unravel the complexity of Parkinson’s disease

Two scientists from NDCN, Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease.

Study shows that non-invasive ultrasound shows promise for treating Parkinson’s disease

Oxford researchers have shown for the first time that ultrasound could have similar effects on brain activity in Parkinson’s sufferers as implanted deep brain stimulation (DBS) electrodes. This opens the door to new treatment approaches that could avoid surgery.